PHARMA, the accredited Common Use Center (CUC) "Biomedical Services" of Technopark "Skolkovo" a contract research organization of ChemRar/ChemDiv group, focusing on conducting clinical trials of investigational drugs developed by Russian and International pharmaceutical and biotech companies in Russia and EAEU.
Our pipeline consists of over 40 clinical trials in oncology, virology, endocrinology, pulmonology, neurology, transplantology, etc. We provide agile clinical services in both early-phase and registration trials, as well as medical, regulatory, and PV expertise to ensure optimal timeline for your drug development. According to Association of Clinical Trials Organizations, IPHARMA has been ranked as a market leader of Russian innovative drugs. (ACTO Analytical report #8 for 2013 and #10 for 2014, #12 for 2015).